HAYMAKER ACQUISITION CORP IV C/WTS 31/05/2028 (TO PUR COM)

Optimi Health

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

HYAC

HYAC.U

HYAC+

RMIX

<p>Haymaker Acquisition reported a net loss of $1.47 million for 2025, down from a net income of $11.32 million in 2024. The loss was attributed to fair-value adjustments to PIPE liabilities and general expenses, despite earning $10.37 million in interest from its Trust Account. The company is pursuing a business combination with Suncrete, securing $167.1 million in PIPE commitments to support operations post-transaction. Management changes have been made to facilitate the merger and governance of the new entity.</p>

TradingView

Haymaker Acquisition Corp 4

Haymaker Acquisition Corp 4 - Unit

Suncrete

Haymaker Acquisition 2025 10-K: Net Loss of $(1.47) M, Trust Interest Income $10.37M

<p>Haymaker Acquisition 4 has postponed its warrantholder meeting regarding the proposed business combination to March 30, 2026, at 9:00 a.m. New York Time. This change affects the timing of the vote on the Business Combination. The proxy statement/prospectus has been filed and sent to shareholders and warrantholders. The completion of the Business Combination is subject to customary conditions, including approvals and the Minimum Cash Condition, with various risk factors noted that could impact timing and outcomes.</p>

Haymaker Acquisition 4 postpones warrantholder meeting to March 30, 2026

HAYMAKER ACQUISITION CORP IV C/WTS 31/05/2028 (TO PUR COM)(HYAC+.US)

Haymaker Acquisition 2025 10-K: Net Loss of $(1.47) M, Trust Interest Income $10.37M

Haymaker Acquisition 4 postpones warrantholder meeting to March 30, 2026